Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06304350
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2024-02-21
Brief Title:
Pembrolizumab Combined With Preoperative Chemotherapy Albumin PaclitaxelCarboplatin Neoadjuvant Therapy for Resectable Locally Advanced Stage IIIII Esophageal Squamous Cell Carcinoma
Sponsor:
Organization:
Tongji University